-+ 0.00%
-+ 0.00%
-+ 0.00%

DYNE THERAPEUTICS REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4) TO NEWLY APPOINTED CHIEF FINANCIAL OFFICER

Reuters·03/20/2025 20:30:00

Please log in to view news